Translational lung cancer research · ·Added 10 Nov 2026

Small-molecule inhibitors and checkpoint inhibitors in KRAS G12C NSCLC: balancing efficacy and toxicity.

Emma D A Wagener, Anneloes L Noordhof, Wouter H van Geffen

DOI ↗

No abstract is available from the indexing sources.